BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 22094219)

  • 21. Long-lasting extreme anemia during the therapy of acute lymphoblastic leukemia in a Jehovah's Witness patient.
    Chojnowski K; Janus A; Bliźniewska K; Robak M; Treliński J
    Transfusion; 2016 Oct; 56(10):2438-2442. PubMed ID: 27385671
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Liver transplant in Jehovah's Witnesses patients.
    Darwish A
    Curr Opin Organ Transplant; 2011 Jun; 16(3):326-30. PubMed ID: 21505338
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Acute lymphoblastic leukaemia in a Jehovah's Witness: a management dilemma.
    Zhou L; Mohsen A; Khan MA; Guthrie T
    J Chemother; 2014 Jun; 26(3):184-6. PubMed ID: 24621157
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Use of a blood substitute in a patient who refuses to accept a transfusion.
    Frackiewicz EJ; Lee R
    Am J Hosp Pharm; 1991 Oct; 48(10):2176; discussion 2176-80. PubMed ID: 1781475
    [No Abstract]   [Full Text] [Related]  

  • 25. Clinical strategies in the medical care of Jehovah's Witnesses.
    Remmers PA; Speer AJ
    Am J Med; 2006 Dec; 119(12):1013-8. PubMed ID: 17145240
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Jehovah's Witnesses and refusal of blood transfusion: the medico-legal challenges.
    Osime CO
    West Afr J Med; 2008 Jul; 27(3):186-90. PubMed ID: 19256328
    [No Abstract]   [Full Text] [Related]  

  • 27. Treatment of anaemia in the polytrauma Jehovah's Witness.
    Murphy DP; O'Donnell T; McDonnell J; McElwain JP
    Ir Med J; 2003 Jan; 96(1):8-10. PubMed ID: 12617434
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bovine hemoglobin: a nontraditional approach to the management of acute anemia in a Jehovah's Witness patient with autoimmune hemolytic anemia.
    Jordan SD; Alexander E
    J Pharm Pract; 2013 Jun; 26(3):257-60. PubMed ID: 22869910
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Case study: Death or damnation--refusing life-prolonging therapy on religious grounds.
    Rousseau P; Stolick M; Morris GM; Ufema J
    Am J Hosp Palliat Care; 2004; 21(6):469-73. PubMed ID: 15612240
    [No Abstract]   [Full Text] [Related]  

  • 30. Changes in policy of refusal of blood by Jehovah's Witnesses. Jehovah's Witnesses respect patients' autonomy.
    Wade P
    BMJ; 2001 May; 322(7294):1124. PubMed ID: 11360912
    [No Abstract]   [Full Text] [Related]  

  • 31. [Refusal of allogeneic blood transfusion by Jehovah's Witnesses. Perioperative management from a legal viewpoint].
    Ulsenheimer K
    Anaesthesist; 2010 Apr; 59(4):312-8. PubMed ID: 20379693
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Recombinant human erythropoietin therapy in critically ill Jehovah's Witnesses.
    Ball AM; Winstead PS
    Pharmacotherapy; 2008 Nov; 28(11):1383-90. PubMed ID: 18956998
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lessons learned from the outcome of bloodless emergency laparotomies on Jehovah's Witness women presenting in the extremis with ruptured uterus.
    Chigbu B; Onwere S; Kamanu C; Aluka C; Okoro O; Feyi-Waboso P; Onichakwe C
    Arch Gynecol Obstet; 2009 Apr; 279(4):469-72. PubMed ID: 18677500
    [TBL] [Abstract][Full Text] [Related]  

  • 34. When blood is not an option: factors affecting survival after the use of a hemoglobin-based oxygen carrier in 54 patients with life-threatening anemia.
    Mackenzie CF; Moon-Massat PF; Shander A; Javidroozi M; Greenburg AG
    Anesth Analg; 2010 Mar; 110(3):685-93. PubMed ID: 20042443
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Jehovah's Witnesses: unique problems in a unique trauma population.
    Victorino G; Wisner DH
    J Am Coll Surg; 1997 May; 184(5):458-68. PubMed ID: 9145065
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The contemporary approach to the care of Jehovah's witnesses.
    Hughes DB; Ullery BW; Barie PS
    J Trauma; 2008 Jul; 65(1):237-47. PubMed ID: 18580506
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The right to refuse treatment and blood transfusion.
    Csapody T
    Bull Med Ethics; 2001 Feb; (165):13-6. PubMed ID: 11831259
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Blood alternative products: correction regarding Jehovah's Witnesses.
    Muller CF
    S Afr Med J; 2009 Feb; 99(2):72, 74; author reply 74. PubMed ID: 19422107
    [No Abstract]   [Full Text] [Related]  

  • 39. Treatment of acute leukaemia in adult Jehovah's Witnesses.
    El Chaer F; Ballen KK
    Br J Haematol; 2020 Sep; 190(5):696-707. PubMed ID: 31693175
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A young adult Jehovah's Witness with severe anemia.
    Ukachi N; Morrison W; Vanhorn S; Sundaram R; Lantos JD
    Pediatrics; 2013 Sep; 132(3):547-51. PubMed ID: 23958767
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.